Latest Cardinal Health Inc. Stories
Cardinal Health to build 64,000 square foot, state-of-the-art facility to manufacture radioactive therapeutic agent used to treat patients with bone metastases from castration-resistant prostate cancer WHIPPANY,
Company Introduces New Antibiotic Analytics Dashboard at ASHP Midyear Clinical Meeting ORANGE COUNTY, Calif., Dec.
DUBLIN, Ohio and MELVILLE, N.Y., Nov. 21, 2014 /PRNewswire/ -- Cardinal Health, Inc. (NYSE: CAH), one of the world's largest health care services companies, and Henry Schein, Inc.
DUBLIN, Ohio, Nov.
DUBLIN, Ohio, Nov. 5, 2014 /PRNewswire/ -- Cardinal Health today announced that the board of directors approved a regular quarterly dividend of $0.3425 per share, payable Jan.
DUBLIN, Ohio, Nov. 3, 2014 /PRNewswire/ -- Healthcare leaders are being pushed hard across the board to lower costs while raising quality.
- Non-GAAP(1) operating earnings increased 6 percent to $566 million DUBLIN, Ohio, Oct.
DUBLIN, Ohio, Oct.
DUBLIN, Ohio, Oct. 9, 2014 /PRNewswire/ -- Cardinal Health plans to release first-quarter financial results for its fiscal year 2015 on Oct.
New Translational Research Center for Molecular Imaging Pharmaceuticals Aims to Research, Develop and Commercialize New Imaging Capabilities COLUMBUS, Ohio, Oct.
- The act of sweetening by admixture of some saccharine substance.